Silexion Therapeutics Ltd.
Market Cap
$8.92K
P/E Ratio
—
EPS
—
Dividend Yield
0.00%
52-Week Range
$0.01 — $0.03
Volume
5.25K
Avg Volume
67.84K
Beta
0.06
Get alerted when SLXNW hits your target price.
Free — enter your email to get started
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.02
P/S (TTM)
0.00
P/B (TTM)
1.26
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-3.88%
ROA (TTM)
-1.65%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.18
Current Ratio
2.41
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+22.08%
EPS Growth (5Y)
+12.68%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-4.12
EPS Est (Next Year)
$-2.23
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.92
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
560.96K
Float
560.96K
Free Float %
100.00%
Sector
Healthcare
Industry
Biotechnology
Country
IL
Exchange
NASDAQ
IPO Date
2024-08-16
Employees
11
CEO
Ilan Hadar
Index Membership
—
Website
https://silexion.com
Silexion Therapeutics Ltd. (SLXNW) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $8.92K, SLXNW is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SLXNW against other stocks using dozens of fundamental and technical filters.
No, Silexion Therapeutics Ltd. (SLXNW) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Silexion Therapeutics Ltd. (SLXNW) has a market capitalization of $8,919, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.